Phasebio Pharmaceuticals Inc(PHAS)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

PHAS Phasebio Pharmaceuticals Inc

盘前交易 11-27 04:52:10 EST

0.0701

+0.0000

0.00%

最高0.0701	最低0.0701	成交量0.00
今开0.0701	昨收0.0701	日振幅0.00%
总市值349.51万	流通市值241.22万	总股本4,986万
成交额0.00	换手率0.00%	流通股本3,441万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"PHAS","market":"US","secType":"STK","nameCN":"Phasebio Pharmaceuticals Inc","latestPrice":0.0701,"timestamp":1683316800000,"preClose":0.0701,"halted":0,"volume":0,"delay":0,"floatShares":34410934,"shares":49858116,"eps":-2.118926,"marketStatus":"盘前交易","marketStatusCode":1,"change":0,"latestTime":"11-27 04:52:10 EST","open":0.0701,"high":0.0701,"low":0.0701,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-2.118926,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1732717800000},"adr":0,"listingDate":1539835200000,"adjPreClose":0.0701,"adrRate":0,"volumeRatio":0},"requestUrl":"/m/hq/s/PHAS/tweets","defaultTab":"tweets","newsList":[{"id":"2277036042","title":"Phasebio Pharmaceuticals Inc盘中异动 快速下挫9.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2277036042","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2277036042?lang=zh_cn&edition=full","pubTime":"2022-10-24 21:31","pubTimestamp":1666618314,"startTime":"0","endTime":"0","summary":"北京时间2022年10月24日21时31分，Phasebio Pharmaceuticals Inc股票出现波动，股价大幅下跌9.04%。Phasebio Pharmaceuticals Inc股票所在的生物技术行业中，整体涨幅为0.52%。Phasebio Pharmaceuticals Inc公司简介：PhaseBio Pharmaceuticals Inc是一家临床阶段的生物制药公司，专注于开发和商业化治疗孤儿病的新型疗法，最初的重点是心肺适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202210242131548233a13e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202210242131548233a13e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PHAS","BK4139"],"gpt_icon":0},{"id":"2270788567","title":"Phasebio Pharmaceuticals Inc盘中异动 早盘股价大涨8.71%报0.850美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2270788567","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2270788567?lang=zh_cn&edition=full","pubTime":"2022-09-27 21:37","pubTimestamp":1664285840,"startTime":"0","endTime":"0","summary":"北京时间2022年09月27日21时37分，Phasebio Pharmaceuticals Inc股票出现波动，股价快速拉升8.71%。Phasebio Pharmaceuticals Inc股票所在的生物技术行业中，整体涨幅为1.58%。其相关个股中，Avenue Therapeutics Inc、Aridis Pharmaceutical Inc、Equillium Inc涨幅较大，Avenue Therapeutics Inc、Kiora Pharmaceuticals Inc、Aditxt Inc较为活跃，换手率分别为679.36%、49.93%、18.39%，振幅较大的相关个股有Avenue Therapeutics Inc、Bellerophon Therapeutics Inc、Abeona Therapeutics Inc，振幅分别为25.28%、21.82%、21.50%。消息层面，截至21时37分，Phasebio Pharmaceuticals Inc股票正面舆情新闻比例100%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20220927213721805b3044&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20220927213721805b3044&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PHAS","BK4139"],"gpt_icon":0},{"id":"2263497281","title":"Phasebio Pharmaceuticals Inc盘中异动 大幅下挫5.31%报1.07美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2263497281","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2263497281?lang=zh_cn&edition=full","pubTime":"2022-08-30 21:32","pubTimestamp":1661866338,"startTime":"0","endTime":"0","summary":"北京时间2022年08月30日21时32分，Phasebio Pharmaceuticals Inc股票出现异动，股价快速下跌5.31%。Phasebio Pharmaceuticals Inc股票所在的生物技术行业中，整体涨幅为0.31%。其相关个股中，In8Bio Inc、Blue Water Vaccines Inc、Virax Biolabs Group Limited涨幅较大，Baudax Bio Inc、In8Bio Inc、Bright Minds Biosciences Inc较为活跃，换手率分别为91.75%、13.37%、12.49%，振幅较大的相关个股有Jounce Therapeutics Inc、Reviva Pharmaceuticals Holdings Inc、In8Bio Inc，振幅分别为10.93%、9.24%、8.08%。Phasebio Pharmaceuticals Inc公司简介：PhaseBio Pharmaceuticals Inc是一家临床阶段的生物制药公司，专注于开发和商业化治疗孤儿病的新型疗法，最初的重点是心肺适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202208302132198058f122&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202208302132198058f122&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PHAS","BK4139"],"gpt_icon":0},{"id":"2261433527","title":"Phasebio Pharmaceuticals Inc盘中异动 下午盘股价大跌5.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2261433527","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2261433527?lang=zh_cn&edition=full","pubTime":"2022-08-23 01:38","pubTimestamp":1661189910,"startTime":"0","endTime":"0","summary":"北京时间2022年08月23日01时38分，Phasebio Pharmaceuticals Inc股票出现波动，股价大幅跳水5.31%。Phasebio Pharmaceuticals Inc股票所在的生物技术行业中，整体跌幅为0.14%。Phasebio Pharmaceuticals Inc公司简介：PhaseBio Pharmaceuticals Inc是一家临床阶段的生物制药公司，专注于开发和商业化治疗孤儿病的新型疗法，最初的重点是心肺适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202208230138318329a764&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202208230138318329a764&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PHAS"],"gpt_icon":0},{"id":"2250963567","title":"Phasebio Pharmaceuticals Inc股价重挫15.83% 市值跌188.14万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2250963567","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2250963567?lang=zh_cn&edition=full","pubTime":"2022-07-11 21:39","pubTimestamp":1657546748,"startTime":"0","endTime":"0","summary":"北京时间2022年07月11日21时39分，Phasebio Pharmaceuticals Inc股票出现异动，股价快速下跌15.83%。Phasebio Pharmaceuticals Inc股票所在的生物技术行业中，整体跌幅为1.17%。Phasebio Pharmaceuticals Inc公司简介：PhaseBio Pharmaceuticals Inc是一家临床阶段的生物制药公司，专注于开发和商业化治疗孤儿病的新型疗法，最初的重点是心肺适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20220711213908828c3d7b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20220711213908828c3d7b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PHAS"],"gpt_icon":0},{"id":"2250769467","title":"Phasebio Pharmaceuticals Inc股价上涨14.44% 市值涨724.18万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2250769467","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2250769467?lang=zh_cn&edition=full","pubTime":"2022-07-09 00:03","pubTimestamp":1657296222,"startTime":"0","endTime":"0","summary":"北京时间2022年07月09日00时03分，Phasebio Pharmaceuticals Inc股票出现异动，股价急速上涨14.44%。截至发稿，该股报1.030美元/股，成交量42.9609万股，换手率0.88%，振幅18.63%。Phasebio Pharmaceuticals Inc股票所在的生物技术行业中，整体涨幅为0.30%。Phasebio Pharmaceuticals Inc公司简介：PhaseBio Pharmaceuticals Inc是一家临床阶段的生物制药公司，专注于开发和商业化治疗孤儿病的新型疗法，最初的重点是心肺适应症。消息层面，截至00时03分，Phasebio Pharmaceuticals Inc股票正面舆情新闻比例100%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202207090003438324b6e1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202207090003438324b6e1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PHAS","BK4139"],"gpt_icon":0},{"id":"2242829561","title":"Phasebio Pharmaceuticals Inc股价飙升10.74% 市值涨347.71万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2242829561","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2242829561?lang=zh_cn&edition=full","pubTime":"2022-06-08 23:10","pubTimestamp":1654701047,"startTime":"0","endTime":"0","summary":"北京时间2022年06月08日23时10分，Phasebio Pharmaceuticals Inc股票出现异动，股价大幅拉升10.74%。Phasebio Pharmaceuticals Inc股票所在的生物技术行业中，整体涨幅为1.15%。其相关个股中，Rubius Therapeutics Inc、Stealth Biotherapeutics Corp、Exicure Inc涨幅较大，Kiora Pharmaceuticals Inc、Exicure Inc、Yumanity Therapeutics Inc较为活跃，换手率分别为48.50%、33.86%、28.37%，振幅较大的相关个股有Kiora Pharmaceuticals Inc、Rubius Therapeutics Inc、Comera Life Sciences Holdings Inc C/Wts 15/03/2027 ，振幅分别为79.95%、40.29%、39.56%。Phasebio Pharmaceuticals Inc公司简介：PhaseBio Pharmaceuticals Inc是一家临床阶段的生物制药公司，专注于开发和商业化治疗孤儿病的新型疗法，最初的重点是心肺适应症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20220608231048828a206e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20220608231048828a206e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PHAS","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.phasebio.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":0.0175},{"period":"1month","weight":0.0373},{"period":"3month","weight":0.0759},{"period":"6month","weight":0.1493},{"period":"1year","weight":0.3216},{"period":"ytd","weight":0.2637}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"PhaseBio Pharmaceuticals, Inc.于2002年1月10日在特拉华州成立。该公司是一家临床阶段的生物制药公司，专注于治疗孤儿疾病的新疗法的开发和商业化，最初的重点是心肺适应症。他们的主要产品PB2452是抗血小板药物替卡格雷的新型逆转剂，他们正在开发新型药物用于治疗正在经历大出血事件的替卡格雷患者或需要紧急手术的患者。该公司最近在健康受试者中完成了PB2452的1期临床试验。他们的第二个候选产品PB1046是一种每周一次的融合蛋白，目前用于治疗肺动脉高压或PAH的2b期临床试验中。PB1046利用其专有的半衰期延长弹性蛋白样多肽或ELP技术，该技术也可作为其临床前管道的引擎。公司保留所有候选产品的全球权利。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.040973},{"month":2,"riseRate":0.2,"avgChangeRate":-0.124917},{"month":3,"riseRate":0.4,"avgChangeRate":0.371332},{"month":4,"riseRate":0.4,"avgChangeRate":0.06721},{"month":5,"riseRate":0.4,"avgChangeRate":0.025307},{"month":6,"riseRate":0.5,"avgChangeRate":-0.032346},{"month":7,"riseRate":0.25,"avgChangeRate":0.068841},{"month":8,"riseRate":0.25,"avgChangeRate":-0.014805},{"month":9,"riseRate":0,"avgChangeRate":-0.37053},{"month":10,"riseRate":0.25,"avgChangeRate":-0.110027},{"month":11,"riseRate":0.2,"avgChangeRate":-0.204981},{"month":12,"riseRate":0.6,"avgChangeRate":0.219493}],"exchange":"NASDAQ","name":"Phasebio Pharmaceuticals Inc","nameEN":"Phasebio Pharmaceuticals Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Phasebio Pharmaceuticals Inc(PHAS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Phasebio Pharmaceuticals Inc(PHAS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Phasebio Pharmaceuticals Inc,PHAS,Phasebio Pharmaceuticals Inc股票,Phasebio Pharmaceuticals Inc股票老虎,Phasebio Pharmaceuticals Inc股票老虎国际,Phasebio Pharmaceuticals Inc行情,Phasebio Pharmaceuticals Inc股票行情,Phasebio Pharmaceuticals Inc股价,Phasebio Pharmaceuticals Inc股市,Phasebio Pharmaceuticals Inc股票价格,Phasebio Pharmaceuticals Inc股票交易,Phasebio Pharmaceuticals Inc股票购买,Phasebio Pharmaceuticals Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Phasebio Pharmaceuticals Inc(PHAS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Phasebio Pharmaceuticals Inc(PHAS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}